NOVALABLatest news

Bring to the table win-win survival strategies to ensure proactive domination. At the end of the day runway heading.
bt_bb_section_bottom_section_coverage_image
< class="bt_bb_headline_tag">Opportunity
" subheadline="<span class="btArticleDate">January 19, 2023</span><span class="btArticleAuthor"><a href="http://www.ammren.org/author/ammren_admin/" class="btArticleAuthorURL">by ammren_admin</a></span>" font="" font_weight="" font_size="" color_scheme="" color="" align="" url="http://www.ammren.org/bbc-hosts-journalism-contest-africa/" target="_self" html_tag="h2" size="normal" dash="" el_id="" el_class="" el_style="" supertitle_position=""]

Professional journalists fluent in English can compete for this award. The BBC is seeking individuals living and working in Africa, who combine strong journalism skills, on-air flair and an exceptional talent in telling African stories for the BBC World News Komla Dumor Award. The winner will receive a three-month training and development opportunity with the BBC in London, starting in early September...

New research has confirmed that a three-dose malaria vaccine is both safe and effective in West African adults, including those previously exposed to malaria. Researchers at the University of Maryland Center for Vaccine Development and Global Health (CVD) led work on the Plasmodium falciparum sporozoite (PfSPZ) vaccine. The clinical trial, which included 80 participants, compared...

According to this year’s World Malaria Report, countries around the world largely held the line against further setbacks to malaria prevention, testing and treatment services in 2021. “Following a marked increase in malaria cases and deaths in the first year of the COVID-19 pandemic, malaria-affected countries redoubled their efforts and were able to mitigate the worst impacts...

Novartis and Medicines for Malaria Venture (MMV) announce decision to move to Phase 3 study for novel non-artemisinin combination to treat uncomplicated malaria ·    This novel combination also contains an optimized formulation of lumefantrine, which allows it to be given once daily versus the usual twice-daily administration ·    As the world faces emerging resistance to current malaria...